Paliperidone palmitate (Invega Trinza®) is an extended-release injectable second-generation (“atypical”) antipsychotic which can be administered once every 3 months. Here is basic information about this medication.
FDA-Approved Indication
Schizophrenia after adequate treatment with 1-month paliperidone palmitate extended-release (Invega Sustenna®) for at least four months.
Dosage
The dose of 3-month paliperidone palmitate (Invega Trinza®) will depend on the last dose of 1-month paliperidone palmitate extended-release (Invega Sustenna) that the patient was on, as follows:
Last dose of |
Starting dose of |
78 mg |
273 mg |
117 mg |
410 mg |
156 mg |
546 mg |
234 mg |
819 mg |
Dosage forms and strengths
Extended-release injectable suspension: 273 mg, 410 mg, 546 mg, 819 mg
Prescribing Information
It is extremely important that prescriber’s review the full prescribing information before prescribing 3-month paliperidone palmitate (Invega Trinza)
See http://www.janssencns.com/shared/product/invegatrinza/prescribing-information.pdf
Related Pages
What should I be doing to monitor patients who are on an antipsychotic? (Free)
Monitoring form for second-generation antipsychotics
Paliperidone palmitate (Invega Sustenna®): Basic Information (Free)
Aripiprazole (Abilify Maintena®)
Aripiprazole lauroxil (Aristada®)
Olanzapine (Zyprexa Relprevv®)
Olanzapine (Zyprexa Relprevv®)
Paliperidone palmitate (Invega Sustenna®)
Long-acting injectable antipsychotics
What are the BEST books on each topic related to psychiatry/ mental health?
Copyright 2015, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Leave a Reply: